1.Expression of RASAL2 in hepatocellular carcinoma and the clinical significance.
Hong SHEN ; Xiaoling WU ; Yan ZHANG ; Ganlu DENG ; Junli MA ; Yanling QU ; Shan ZENG
Journal of Central South University(Medical Sciences) 2015;40(3):250-255
OBJECTIVE:
To detect the expression of RA SAL2 in patients with hepatocellular carcinoma (HCC), and to investigate the association of RASAL2 expression with pathological characteristics and prognosis.
METHODS:
Immunohistochemical SP method was used to detect the expression of RA SAL2 in 164 samples of HCC tissue and the adjacent tissue. Th e association of RA SAL2 expression with clinical features and prognosis was analyzed.
RESULTS:
The expression of RASAL2 in adjacent tissue was significantly increased compared to that in HCC tissue (P<0.001). The expression level of RASAL2 was associated with the degree of differentiation, tumor TNM stage and vascular invasion (P<0.001), but not associated with the level of AFP, tumor size, or the number of nodules (P>0.05). The 5 years recurrence-free survival (RFS) in patients with low expression of RASLA2 was significantly reduced compared with that in patients with high expression of RASLA2 (P<0.001). Cox analysis showed that low expression of RASLA2 was the independent factor for recurrence and death in HCC patients after surgery (P<0.001).
CONCLUSION
Low expression of RRASAL2 is significantly associated with the poor prognosis of HCC, which is an independent factor for HCC prognosis.
Carcinoma, Hepatocellular
;
genetics
;
metabolism
;
Carrier Proteins
;
genetics
;
metabolism
;
Humans
;
Liver Neoplasms
;
genetics
;
metabolism
;
Neoplasm Recurrence, Local
;
Prognosis
2.Mechanisms of microRNA action in rectal cancer radiotherapy.
Lili ZHU ; Mojin WANG ; Na CHEN ; Yujie ZHANG ; Tao XU ; Wen ZHUANG ; Shuomeng XIAO ; Lei DAI
Chinese Medical Journal 2022;135(17):2017-2025
Preoperative neoadjuvant chemoradiotherapy, combined with total mesorectal excision, has become the standard treatment for advanced localized rectal cancer (RC). However, the biological complexity and heterogeneity of tumors may contribute to cancer recurrence and metastasis in patients with radiotherapy-resistant RC. The identification of factors leading to radioresistance and markers of radiosensitivity is critical to identify responsive patients and improve radiotherapy outcomes. MicroRNAs (miRNAs) are small, endogenous, and noncoding RNAs that affect various cellular and molecular targets. miRNAs have been shown to play important roles in multiple biological processes associated with RC. In this review, we summarized the signaling pathways of miRNAs, including apoptosis, autophagy, the cell cycle, DNA damage repair, proliferation, and metastasis during radiotherapy in patients with RC. Also, we evaluated the potential role of miRNAs as radiotherapeutic biomarkers for RC.
Humans
;
MicroRNAs/metabolism*
;
Neoplasm Recurrence, Local
;
Rectal Neoplasms/pathology*
;
Neoadjuvant Therapy
;
Radiation Tolerance/genetics*
3.Expression and significance of C/EBPα and CK10 in nasal inverted papilloma.
Yibing YAUN ; Xianying MENG ; Xu WU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2015;29(5):437-440
OBJECTIVE:
The expression of C/EBPα, CK10 in nasal inverted papilloma (NIP) were detected in the study. Further discussed their significance in genesia, development and recurrence of NIP.
METHOD:
Three groups including nasal cavity mucosae (NM 10 cases), nasal polyp (NP 20 cases) and NIP (30 cases) were selected in the study. Expretion of C/EBPα, CK10 were detected by immunohistochemisty PV-6000 method.
RESULT:
(1) The different expression of C/EBPα and CK10 in the group of NM, NP and NIP was statistically significant (P < 0.05). (2) The different expression of C/EBPα, CK10 in the group of benign NIP and NIP with atypical hyperplasia was statistically significant (P < 0.05). (3) The different expression of C/EBPα and CK10 in the group of NIP with recurrence and NIP with no recurrence was statistically significant, P < 0.05, respectively. (4) Our result indicate that the relationship of C/EBPα and CK10 (r = 0.578, P < 0.01) was direct correlation. The difference was statistically significant.
CONCLUSION
In conclusion, the present results describe C/EBPα, CK10 expression in NIP and their possible implication in the regulation of tumor growth and differentiation. C/EBPα and CK10 production may prove useful in terms of a prognostic marker for the recurrence in nasal inverted papilloma.
CCAAT-Enhancer-Binding Proteins
;
genetics
;
metabolism
;
Humans
;
Keratin-10
;
genetics
;
metabolism
;
Nasal Polyps
;
genetics
;
metabolism
;
Neoplasm Recurrence, Local
;
Nose
;
Nose Neoplasms
;
genetics
;
metabolism
;
Papilloma, Inverted
;
genetics
;
metabolism
4.Comprehensive analysis identifies as a critical prognostic prediction gene in breast cancer.
Ting HU ; Xu WANG ; Yun XIA ; Lu WU ; Yuxi MA ; Rui ZHOU ; Yanxia ZHAO
Chinese Medical Journal 2022;135(18):2218-2231
BACKGROUND:
Aurora kinases (AURKs) family plays a vital role not only in cell division but also in tumorigenesis. However, there are still rare systematic analyses of the diverse expression patterns and prognostic value of the AURKs family in breast cancer (BC). Systematic bioinformatics analysis was conducted to explore the biological role, prognostic value, and immunologic function of AURKs family in BC.
METHODS:
The expression, prognostic value, and clinical functions of AURKs family in BC were evaluated with several bioinformatics web portals: ONCOMINE Gene Expression Profiling Interactive Analysis, Kaplan-Meier plotter, cBioPortal, Metascape, GeneMANIA, and LinkedOmics; and the result was verified using human tissues.
RESULTS:
The expression of AURKA and AURKB were upregulated in BC in subgroup analyses based on tumor stage (all P < 0.05). BC patients with high AURKA and AURKB expression had a worse overall survival, relapse-free survival, and distant metastasis-free survival (all P < 0.05). Verification experiment revealed that AURKA and AURKB were upregulated in BC ( P < 0.05). AURKA and AURKB were specifically associated with several tumor-associated kinases (polo-like kinase 1 and cyclin-dependent kinase 1), miRNAs (miR-507 and miR-381), and E2F transcription factor 1. Moreover, AURKA and AURKB were correlated with immune cell infiltration. Functional enrichment analysis revealed that AURKA and AURKB were involved in the cell cycle signaling pathway, platinum drug resistance signaling pathway, ErbB signaling pathway, Hippo signaling pathway, and nucleotide-binding and oligomerization domain-like receptor signaling pathway.
CONCLUSIONS
Aurora kinases AURKA and AURKB could be employed as novel prognostic biomarkers or promising therapeutic targets for BC.
Humans
;
Female
;
Aurora Kinase A/metabolism*
;
Aurora Kinase B/metabolism*
;
Prognosis
;
Breast Neoplasms/genetics*
;
Neoplasm Recurrence, Local
;
MicroRNAs
5.Expression of miR-126/miR-126* in hepatocelluar carcinoma and its correlation with clinical outcomes.
Hua HE ; Yu HUANG ; Dinghua YANG ; Bo LIANG ; Liang LIN ; Jia-Lu LI ; Hui LIAO ; Botang GUO
Journal of Southern Medical University 2014;34(10):1493-1497
OBJECTIVETo investigate the expression of miR-126/miR-126* in hepatocellular carcinoma (HCC) tissues and its clinical significance.
METHODSThe expressions of miR-126/miR-126* in the tumor tissues and non-cancer tissues from 74 HCC cases were detected using real-time quantitative PCR. The correlation between miR-126/miR-126* expression and the clinicopathological features of the patients was analyzed.
RESULTSCompared with the non-cancer tissues, HCC tissues showed significantly lowered expression levels of miR-126/miR-126*. A positive correlation was found between the expressions of miR-126 and miR-126* in the tumor tissues. Lower expressions of miR-126/miR-126* were significantly correlated with tumor recurrence and poor survival of the HCC patients.
CONCLUSIONThe down-regulation of miR-126/miR-126* may play an important role in HCC metastasis and contributes to poor survival of HCC patients.
Carcinoma, Hepatocellular ; genetics ; metabolism ; Down-Regulation ; Humans ; Liver Neoplasms ; genetics ; metabolism ; MicroRNAs ; genetics ; metabolism ; Neoplasm Recurrence, Local ; Real-Time Polymerase Chain Reaction
6.Expression of special AT-rich sequence-binding protein 1 mRNA in hepatocellular carcinoma and its clinical significance.
Zheng-kui PENG ; Ding-hua YANG ; Xiang-hong LI ; Yu HUANG ; Guo-qiang ZHANG ; Ke-bo ZHONG ; Min-ping BI ; Guang-hui LI
Journal of Southern Medical University 2011;31(7):1207-1211
OBJECTIVETo investigate the expression of special AT-rich sequence binding protein 1 (SATB1) mRNA in hepatocellular carcinoma (HCC) and explore its correlation to the clinicopathological features, surgical outcomes and metastasis of HCC.
METHODSThe total RNA was extracted from 102 HCC tissues and the adjacent tissues, and the expression of SATB1 mRNA was detected using quantitative real-time PCR. The correlations of SATB1 mRNA expression to the clinicopathological features, postoperative recurrence and metastasis of the tumor were analyzed.
RESULTSThe expression of SATB1 mRNA in HCC tissues was 3.27 folds higher than that in the adjacent tissues (P<0.001). The expression of SATB1 mRNA in HCC was associated with liver cirrhosis, AFP level, tumor size, tumor thrombi, histological differentiation, TNM classification, postoperative recurrence and metastasis (P<0.05), but not to the patients' gender, age, HbsAg positivity, HCV-Ab positivity, tumor number, or the presence of tumor encapsulation (P>0.05). In patients with significant high expression, high expression, and low expression of SATB1 mRNA, the postoperative recurrence rates were 82.68%, 0, and 0, with the 3-year survival rate of 0, 52.63%, and 100%, respectively.
CONCLUSIONSATB1 mRNA expression is associated with the postoperative recurrence and metastasis of HCC, and can be used as an indicator for predicting the recurrence and metastasis of HCC.
Aged ; Carcinoma, Hepatocellular ; genetics ; metabolism ; Female ; Humans ; Liver Neoplasms ; genetics ; metabolism ; Male ; Matrix Attachment Region Binding Proteins ; genetics ; metabolism ; Middle Aged ; Neoplasm Metastasis ; diagnosis ; Neoplasm Recurrence, Local ; diagnosis ; RNA, Messenger ; genetics ; metabolism ; Real-Time Polymerase Chain Reaction ; methods
7.Recent advances in basic research on primary liver cancer.
Chinese Journal of Hepatology 2004;12(11):641-642
8.New challenges of HER2 testing in breast cancer.
Fei YANG ; Wen-tao YANG ; Hong BU
Chinese Journal of Pathology 2012;41(5):289-292
Breast Neoplasms
;
diagnosis
;
genetics
;
metabolism
;
Carcinoma, Intraductal, Noninfiltrating
;
genetics
;
metabolism
;
Chromosomes, Human, Pair 17
;
genetics
;
Female
;
Genetic Heterogeneity
;
Humans
;
Immunohistochemistry
;
In Situ Hybridization, Fluorescence
;
Neoplasm Metastasis
;
Neoplasm Recurrence, Local
;
Polyploidy
;
Receptor, ErbB-2
;
genetics
;
metabolism
9.Dynamic detection of chimerism and fusion gene in chronic myeloid leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation.
Jing-Fen SUN ; Dan-Dan ZHAO ; Xiao-Ping HAN ; Hong-Shi JIN ; Li YU
Journal of Experimental Hematology 2008;16(4):833-837
This study was aimed to investigate the chimerism and fusion gene expression in patients with CML after allo-HSCT, to analyse engraftment and minimal residual disease by using STR-PCR combined with RT-PCR qualitative and quantitative assays, and to evaluate their clinical value for predicting disease relapse. 4 relapsed patients with CML after allo-HSCT were dynamically investigated. Qualitative analysis of donor chimerism was performed by multiplex PCR amplification of STR markers and capillary electrophoresis with fluorescence detection, qualitative detection of bcr/abl transcripts was performed by RT-PCR. The results showed that the 100% donor chimerism appeared in 4 patients on day 28 after transplantation and bcr/abl expression was negative, but the 4 patients were in status of unstable mixed chimerism (DC: 0% - 80.4%) at the different time points during the following up with bcr/abl gene positive. 2 patients of them were continuously mixed chimerism after relapse of CML, the other 2 changed from MC to CC by intervention of clinical treatment. Decreasing values of donor chimerism were detected prior to the occurrence of graft rejection and CML relapse, and bcr/abl gene expression was positive. It is concluded that the results of STR-PCR in the range of its sensitivity fully correspond with bcr/abl tests in patients. The combination of STR-PCR with RT-PCR will provide a highly sensitive and valuable tool for evaluating engraftment, graft rejection, and relapse and predicting GVHD. Furthermore, it can provide a basis for early intervention of clinical treatment, and can identify these high risk patients with molecular or cytogenetic relapse after allo-HSCT.
Fusion Proteins, bcr-abl
;
genetics
;
metabolism
;
Hematopoietic Stem Cell Transplantation
;
adverse effects
;
Humans
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
genetics
;
therapy
;
Neoplasm Recurrence, Local
;
genetics
;
Neoplasm, Residual
;
diagnosis
;
genetics
;
RNA, Messenger
;
genetics
;
metabolism
;
Transplantation Chimera
;
Transplantation, Homologous
10.Expression of lymphatic vessel endothelial hyaluronan receptor-1 in human colorectal cancer and its clinical significance.
Zhan-xia LI ; Guo-feng ZHANG ; Zhi-qian HU ; Yue-zu FAN
Chinese Journal of Gastrointestinal Surgery 2009;12(5):511-514
OBJECTIVETo examine the expression of lymph vessel endothelial hyaluronan receptor-1 (LYVE-1) in human colorectal carcinoma and to evaluate the relationship of LYVE-1 with lymph mode metastasis and prognosis.
METHODSColonic cancer samples of 40 cases were collected. The expression of LYVE-1 was determined by RT-PCR and quantified by real-time quantitative PCR. LVD and MVD were detected by immunohistochemistry staining. The relationship of LYVE-1 and LVD with lymph mode metastasis and prognosis were analyzed. All the patients were followed up for at least 3 years.
RESULTSThe expression of LYVE-1 and the count of LVD were significantly higher in tumor tissue than those in common colon tissue (P<0.05). In the majority of tumors, the higher count of LVD indicated lymphangiogenesis. The recurrence rates in low LVD group and high LVD group were 46.7% and 60.0% respectively (P<0.05). The survival rates in the above two groups were 90.1% and 56.7% respectively (P<0.05). No significant correlation was found between LYVE-1 and recurrence rate (P>0.05) or overall survival (P>0.05).
CONCLUSIONLYVE-1 indicates an increase of lymphangiogenesis in colorectal carcinoma and LVD can be used to evaluate the prognosis for colorectal cancer patients.
Adult ; Aged ; Colorectal Neoplasms ; metabolism ; pathology ; Female ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Prognosis ; RNA, Messenger ; genetics ; Vesicular Transport Proteins ; metabolism